NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $306,000 | +34.2% | 42,179 | +88.0% | 0.00% | – |
| Q3 2017 | $228,000 | -26.2% | 22,431 | -46.6% | 0.00% | -100.0% |
| Q2 2017 | $309,000 | -93.1% | 42,006 | -77.5% | 0.00% | -87.5% |
| Q1 2017 | $4,492,000 | +285.9% | 186,378 | +64.5% | 0.01% | +300.0% |
| Q4 2016 | $1,164,000 | +167.0% | 113,302 | +290.3% | 0.00% | +100.0% |
| Q3 2016 | $436,000 | +47.3% | 29,030 | +10.4% | 0.00% | 0.0% |
| Q2 2016 | $296,000 | -80.1% | 26,284 | -67.8% | 0.00% | -66.7% |
| Q1 2016 | $1,485,000 | -21.0% | 81,603 | +58.1% | 0.00% | 0.0% |
| Q4 2015 | $1,879,000 | +17.0% | 51,617 | +15.2% | 0.00% | +50.0% |
| Q3 2015 | $1,606,000 | -26.7% | 44,817 | -9.4% | 0.00% | -33.3% |
| Q2 2015 | $2,190,000 | +599.7% | 49,460 | +527.3% | 0.00% | – |
| Q4 2014 | $313,000 | -61.9% | 7,884 | -79.4% | 0.00% | -100.0% |
| Q3 2014 | $822,000 | -37.2% | 38,363 | -22.2% | 0.00% | -50.0% |
| Q2 2014 | $1,309,000 | +346.8% | 49,317 | +378.8% | 0.00% | – |
| Q1 2014 | $293,000 | -77.5% | 10,300 | -82.6% | 0.00% | -100.0% |
| Q4 2013 | $1,305,000 | – | 59,284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |